John Chiminski
President and Chief Executive Officer, Catalent
Meet John Chiminski
“We are honored that our customers put their patients’ needs directly in our hands. Though patients may not know us by name, they rely on our ‘patient first’ culture. Our initial public offering in July 2014 was undoubtedly a pivotal moment in taking our organization to the next level – enabling us to bring more life-saving patient-centric treatments to market.”
“Across the industry as a whole, I would like to see continued commitment to developing treatments that demonstrate real world results for patients. This could be fuelled by better understanding patient needs, more innovative drug delivery technologies, or through more collaboration – including helping our partners ‘rescue’ promising but difficult to deliver molecules.”